Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats

Life Sciences

Volumn 72, Issue 11, 2003, Pages 1231-1245

  Kim, Eun Jung ^a   Suh, Ok Kyung ^a   Lee, Myung Gull ^a  

^a Seoul National University   (South Korea)

Author keywords

1,3 DMU; CYP1A2; Mutant Nagase analbuminemic rats; Pharmacokinetics; Theophylline

Indexed keywords

1 METHYLURIC ACID; 1,3 DIMETHYLURIC ACID; AMINOPHYLLINE; CYTOCHROME P450 1A2; THEOPHYLLINE;

ANALBUMINEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE CALCULATION; IN VITRO STUDY; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EXCRETION; LIVER MICROSOME; MALE; NONHUMAN; RAT; RAT STRAIN; TIME;

ANIMALS; AREA UNDER CURVE; BLOOD PROTEIN DISORDERS; CYTOCHROME P-450 CYP1A2; ENZYME INDUCTION; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; THEOPHYLLINE; URIC ACID;

ANIMALIA;

EID: 0037473836     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02373-1     Document Type: Article

References (36)

1. Nagase S., Shimamune K., Shumiya S. Albumin-deficient rat mutant: An animal model for analbuminemia. Experimental Animals. 29(1):1980;33-38.
2. Okajima K., Inoue M., Itoh K., Nagase S., Morino Y. Role of albumin in renal elimination of a mercapturic acid: Analyses in normal and mutant analbuminemic rats. European Journal of Biochemistry. 50(1):1985;195-199.
3. Inoue M., Koyama H., Nagase S., Morino Y. Renal secretion of phenolsulfonphthalein: analysis of its vectorial transport in normal and mutant analbuminemic rats. Journal of Laboratory and Clinical Medicine. 105(4):1985;484-488.
4. Inoue M., Koyama H., Nagase S., Morino Y. Hepato-renal transport of phenolsulfophthalein in analbuminemic rats: Albumin is essential for hepatic compensatory elimination of a nephrophilic ligand in animals with renal dysfunction. Journal of Biochemistry. 100(1):1986;201-206.
5. Inoue M., Okajima K., Itoh K., Ando Y., Watanabe N., Yasaka T., Nagase S., Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney International. 32(2):1987;198-203.
6. Hirate J., Zhu C., Horikoshi I., Nagase S. Disposition of warfarin in analbuminemic rats. International Journal of Pharmaceutics. 65:1990;149-157.
7. Kim E.J., Lee M.G. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects. Biopharmaceutics and Drug Disposition. 22(4):2001;147-156.
8. Hirate J., Kato Y., Horikoshi I., Nagase S., Ueda C.T. Further observations on the disposition characteristics of salicylic acid in analbuminemic rats. Biopharmaceutics and Drug Disposition. 10(3):1989;299-309.
9. Teunissen M.W., Brorens I.O., Geerlings J.M., Breimer D.D. Dose-dependent elimination of theophylline in rats. Xenobiotica. 15(2):1985;165-171.
10. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.T. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
11. Sarkar M.A., Jackson B.J. Theophylline N-demethylations as probes for P4501A1 and P4501A2. Drug Metabolism and Disposition. 22(6):1994;827-834.
12. Lineweaver H., Burk D. The determination of enzyme dissociation constants. Journal of the American Chemical Society. 56:1934;658-666.
13. Kawakatsu K., Nishimura K., Kawai M., Chikuma M. Separation and determination of theophylline from paraxanthine in human serum by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 7(8):1989;965-973.
14. Lee S.H., Lee M.G. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique. Biopharmaceutics and Drug Disposition. 16(7):1995;615-626.
15. Chiou W.L. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinetics and Biopharmaceutics. 6(6):1978;539-546.
16. Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed. 1982;Dekker, New York.
17. Kim S.H., Choi Y.M., Lee M.G. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. Journal of Pharmacokinetics and Biopharmaceutics. 21(1):1993;1-17.
18. Chiou W.L. New calculation method of mean total body clearance of drugs and its application to rational dosage regimens. Journal of Pharmaceutical Sciences. 69(1):1980;90-91.
19. Chiou W.L. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimen. Journal of Pharmaceutical Sciences. 68(8):1979;1067-1069.
20. Eatman F.B., Colburn W.A., Boxenbaum H.G., Posmanter H.N., Weinfeld R.E., Ronfeld R., Moore J.D., Gibaldi M., Kaplan S.A. Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. Journal of Pharmacokinetics and Biopharmaceutics. 5(5):1977;481-494.
21. Lesko L.J. Dose-dependent elimination kinetics of theophylline. Clinical Pharmacokinetics. 4(6):1979;449-459.
22. Birkett D.J., Dahlqvist R., Billing B., Miners J.O. Dose dependency of theophylline metabolism. Clinical and Experimental Pharmacology and Physiology. 8:1984;48-49.
23. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharmaceutical Research. 10(7):1993;1093-1095.
24. Kuh H.J., Shim C.K. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats. Archives of Pharmacal Research. 17(2):1994;124-130.
25. Mitruka B.M., Rawnsley H.M. Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals and Normal Humans. 2nd ed. 1982;Masson Publishing, New York.
26. Nakura H., Tateishi T., Watanabe M., Asoh M., Tanaka M., Kumai T., Kobayashi S. Effect of hypoalbuminemia on the disposition of theophylline. Comparative study with Sprague-Dawley rats and a mutant Sprague-Dawley hyperlipidemic strain with hypoalbuminemia. Drug Metabolism and Disposition. 26(6):1998;595-597.
27. Inoue M., Morino Y., Nagase S. Transhepatic transport of taurocholic acid in normal and mutant analbuminemic rats. Biochimica et Biophysica Acta. 833:1985;211-216.
28. Hirate J., Horikoshi I., Nagase S. Disposition of phenytoin in analbuminemic rats. Biopharmaceutics and Drug Disposition. 11:1990;773-783.
29. Takada K., Kawamura T., Inai M., Masuda S., Oka T., Yoshikawa Y., Shibata N., Yoshikawa H., Ike O., Wada H., Hitomi S. Pharmacokinetics of cisplatin in analbuminemic rats. Biopharmaceutics and Drug Disposition. 20:1999;421-428.
30. Inoue M., Hirate E., Morino Y., Nagase S., Chowdhury J.R., Chowdhury N.R., Arias I.M. The role of albumin in the hepatic transport of bilirubin: Studies in mutant analbuminemic rats. Journal of Biochemistry. 97(3):1985;737-743.
31. Inoue M., Okajima K., Nagase S., Morino Y. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: Is plasma albumin essential for vectorial transport of organic anions in the liver? Proceedings of the National Academy of Sciences of the United States of America. 80:1983;7654-7658.
32. Hirate J., Horikoshi I., Watanabe J., Ozeki S., Nagase S. Disposition of salicylic acid in analbuminemic rats. Journal of Pharmacobio-Dynamics. 7:1984;929-934.
33. Kim EJ, Lee MG. Pharmacokinetics and pharmacodynamics of intravenous torasemide in mutant Nagase analbuminemic rats. Biopharmaceutics and Drug Disposition [in press].
34. Nagase S., Shimamune K., Shumiya S. Albumin deficient rat mutant. Science. 205:1979;590-591.
35. Green T.P., Mirkin B.L. Furosemide disposition in normal and proteinuretic rats: urinary drug-protein binding as a determinant of drug excretion. Journal of Pharmacology and Experimental Therapeutics. 218(1):1981;122-127.
36. Chung S.Y., Yoon W.H., Kim S.H., Hwang K.S., Lee M.G. Arterial and venous blood sampling in pharmacokinetic studies: bumetanide in rabbits. Research Communications in Molecular Pathology and Pharmacology. 98(3):1997;255-264.